全文获取类型
收费全文 | 2606篇 |
免费 | 227篇 |
专业分类
2833篇 |
出版年
2022年 | 58篇 |
2021年 | 81篇 |
2020年 | 39篇 |
2019年 | 45篇 |
2018年 | 76篇 |
2017年 | 61篇 |
2016年 | 77篇 |
2015年 | 114篇 |
2014年 | 125篇 |
2013年 | 141篇 |
2012年 | 205篇 |
2011年 | 152篇 |
2010年 | 101篇 |
2009年 | 73篇 |
2008年 | 101篇 |
2007年 | 87篇 |
2006年 | 93篇 |
2005年 | 72篇 |
2004年 | 65篇 |
2003年 | 66篇 |
2002年 | 60篇 |
2001年 | 49篇 |
2000年 | 46篇 |
1999年 | 41篇 |
1998年 | 24篇 |
1997年 | 18篇 |
1996年 | 16篇 |
1995年 | 23篇 |
1994年 | 21篇 |
1992年 | 33篇 |
1991年 | 37篇 |
1990年 | 41篇 |
1989年 | 33篇 |
1988年 | 48篇 |
1987年 | 34篇 |
1986年 | 27篇 |
1985年 | 37篇 |
1984年 | 28篇 |
1983年 | 26篇 |
1982年 | 24篇 |
1981年 | 18篇 |
1980年 | 15篇 |
1979年 | 25篇 |
1977年 | 19篇 |
1976年 | 16篇 |
1975年 | 27篇 |
1974年 | 31篇 |
1973年 | 27篇 |
1972年 | 17篇 |
1968年 | 16篇 |
排序方式: 共有2833条查询结果,搜索用时 15 毫秒
151.
Yogavel Manickam Nipun Malhotra Siddhartha Mishra Palak Babbar Abhishek Dusane Benoît Laleu Valeria Bellini Mohamed-Ali Hakimi Alexandre Bougdour Amit Sharma 《PLoS pathogens》2022,18(3)
Toxoplasmosis is caused by Toxoplasma gondii and in immunocompromised patients it may lead to seizures, encephalitis or death. The conserved enzyme prolyl-tRNA synthetase (PRS) is a validated druggable target in Toxoplasma gondii but the traditional ‘single target–single drug’ approach has its caveats. Here, we describe two potent inhibitors namely halofuginone (HFG) and a novel ATP mimetic (L95) that bind to Toxoplasma gondii PRS simultaneously at different neighbouring sites to cover all three of the enzyme substrate subsites. HFG and L95 act as one triple-site inhibitor in tandem and form an unusual ternary complex wherein HFG occupies the 3’-end of tRNA and the L-proline (L-pro) binding sites while L95 occupies the ATP pocket. These inhibitors exhibit nanomolar IC50 and EC50 values independently, and when given together reveal an additive mode of action in parasite inhibition assays. This work validates a novel approach and lays a structural framework for further drug development based on simultaneous targeting of multiple pockets to inhibit druggable proteins. 相似文献
152.
153.
Amit Kumar Solanki Abhishek Acharya Himani Kaushik Bharti Bhatia Lalit C Garg 《Bioinformation》2021,17(6):628
Beta toxin from Clostridium perfringens after being secreted in gut is capable of causing necrotic enteritis in humans and several other animal species and does not respond to routinely used antibiotics. Therefore, there is a need to design an effective inhibitor for the Clostridium perfringens beta toxin (CPB) using cutting edge drug discovery technologies. Hence, potential CPB inhibitors were identified using computer aided screening of compounds from the ZINC database. Further, we document the molecular docking analysis of Clostridium perfringens beta toxin model (that revealed 4 binding pockets, A-D) with the identified potential inhibitors. We show that ZINC291192 [N-[(1-methylindol-3-yl) methyl eneamino]-7,10-dioxabicyclo[4.4.0]deca-2,4,11-triene-8- carboxamide] has optimal binding features with calculated binding energy of -10.38 kcal/mol and inhibition constant of 24.76 nM for further consideration. 相似文献
154.
155.
Wen Yen Li Dhruba J. Chatterjee Bhasker V. Shetty Ellen Y. Wu Franco Muggia Robert T. Koda 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》1995,673(2)
AG 331 is a novel thymidylate synthase inhibitor currently in Phase I clinical trial. To determine the pharmacokinetic parameters of AG 331 in human subjects, a suitable analytical method was developed using high-performance liquid chromatography. Serum and urine samples were prepared using both solid-phase extraction and solvent extraction. Either 4,4′-diaminodiphenyl sulfone or benz[cd]indole-2(1H)-one were used as internal standards for the method. A reversed-phase C18 analytical column completely resolved the drug and internal standard peaks from non-specific substances present in biological matrix. The method was validated for precision, accuracy, and reproducibility in serum and was linear over a concentration range of 50–2000 ng/ml, with a limit of detection of 20.0 ng/ml and a quantifiable limit of 50 ng/ml. 相似文献
156.
157.
Habib AA Chatterjee S Park SK Ratan RR Lefebvre S Vartanian T 《The Journal of biological chemistry》2001,276(12):8865-8874
158.
Vitamin D and genomic stability 总被引:7,自引:0,他引:7
Chatterjee M 《Mutation research》2001,475(1-2):69-87
159.
160.
Neutral sphingomyelinase: past, present and future 总被引:2,自引:0,他引:2
Chatterjee S 《Chemistry and physics of lipids》1999,102(1-2):79-96
Sphingomyelin and its metabolic products are now known to have second messenger functions in a variety of cellular signaling pathways. At the epicenter of the sphingomyelin--cell signaling pathway is a family of phospholipases called sphingomyelinases. These enzymes cleave sphingomyelin to produce ceramide and phosphocholine. Ceramide in turn serves as a lipid second messenger that induces a variety of cell regulatory phenomenon such as programmed cell death (apoptosis), cell differentiation, cell proliferation, and sterol homeostasis. Neutral sphingomyelinase (N-SMase) is a Mg2+ sensitive enzyme that can be activated by a host of physiologically relevant and structurally diverse molecules like tumor necrosis factor-alpha (TNF-alpha), oxidized human low density lipoproteins (Ox-LDL), and several growth factors. Large amounts of ceramide accumulate in human fatty streaks and plaques along with Ox-LDL, growth factors, and proinflammatory cytokines in human atherosclerosis. A further role of ceramide and N-SMase in atherosclerosis was uncovered by the finding that Ox-LDL and TNF-alpha stimulated N-SMase activity. In turn, ceramide and/or a homolog serves as an important stress signaling molecule in signal transduction, which leads to apoptosis. Interestingly, an antibody against N-SMase can abrogate Ox-LDL and TNF-alpha induced apoptosis, and therefore may be useful for additional studies of apoptosis in experimental animals. Overexpression of recombinant human N-SMase in human aortic smooth muscle cells markedly stimulate apoptosis, presumably via the multioligomerization of the 'death domain'. Since plaque stability is an integral aspect of atherosclerosis management, activation of N-SMase and subsequent apoptosis may be vital events in the onset of plaque rupture, stroke and heart failure. In contrast to these observations in human hepatocytes, TNF-alpha mediated N-SMase activation did not induce apoptosis. Rather it stimulated the maturation of sterol regulatory element (SRE) binding protein (SREBP-1). Moreover, a cell permeable ceramide was found to reconstitute the phenomenon above in a sterol-independent fashion. These findings provide alternate avenues for therapy of patients with hypercholesterolemia and atherosclerosis. The findings reported here suggests that N-SMase plays important cell regulatory roles and provide an exciting opportunity to further these findings to understand the pathophysiology of human disease states. 相似文献